概括
新的指导方针标准化了中国肝细胞癌的外部辐射疗法. 这种专家共识旨在提高肝癌患者的治疗效果,减少副作用.
科学领域:
- 肝胆瘤学
- 辐射瘤学
- 临床实践指南
背景情况:
- 肝细胞癌 (HCC) 是中国的主要恶性瘤.
- 外部辐射疗法 (RT) 是HCC的有效治疗选择,在2024年指南中承认.
- 针对HCC的RT标准化对于最佳的患者结果至关重要.
研究的目的:
- 建立一个专家的共识,用于在HCC中临床实施RT.
- 在HCC治疗中提供标准化的RT指导.
- 提高RT治疗肝癌的疗效和安全性.
主要方法:
- 由中国肝癌协会制定专家共识.
- 专家们进行了多轮讨论.
- 共识涵盖了关键的RT元素:目的,目标/剂量,技术,组合和后续行动.
主要成果:
- 达成共识包括10项建议.
- 这些关键要素包括RT的作用,目标划定,剂量处方,先进的RT技术,多模式治疗整合和治疗后监测.
- 这项共识旨在使临床医生熟悉标准化RT协议.
结论:
- 标准化RT协议对于HCC管理至关重要.
- 这种专家共识为临床医生提供了有效利用高血压的框架.
- 预计这些建议的实施将提高治疗结果,并尽量减少接受RT的HCC患者的不良反应.
相关概念视频
Targeted Cancer Therapies
7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.8K
Cancer Survival Analysis
453
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
453
Treatment Resistant Cancers
3.4K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.4K


